Titlebook: Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis; Renato Alberto Sinico,Lo?c Guillevin Book 2020 Springer Nature Switzerl

貪污

書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis影響因子(影響力)




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis影響因子(影響力)學科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis網(wǎng)絡公開度




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis網(wǎng)絡公開度學科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis被引頻次




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis被引頻次學科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis年度引用




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis年度引用學科排名




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis讀者反饋




書目名稱Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis讀者反饋學科排名

Nerve-Block

intrigue

Introduction: Nomenclature and Classificationation and diagnosis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Physicians and scientists have made remarkable advances in the classification and diagnosis of vasculitides since the seminal observations in the 1800s; however, validated and widely applied classification

Popcorn

Genetics of ANCA-Associated Vasculitis in complex susceptibility loci and disease mechanisms. Finally, we discuss the limitations of current methods and the challenges that we still have to approach in order to translate genomic and epigenomic data into clinical practice.

衰弱的心

ANCA: Methods and Clinical Significanceoassays for PR3-ANCA and MPO-ANCA. New guidelines for ANCA testing have been developed based on a recent European multicenter study, and according to the revised 2017 international consensus recommendations, testing for ANCA in small-vessel vasculitis can be done by PR3-ANCA and MPO-ANCA immunoassay

Frisky

Interregnum

Nonflammable

Granulomatosis with Polyangiitisccurring within 1?year of the first symptoms. With current treatments, which include first an induction phase, based on the combination of corticosteroids and an immunosuppressant, then a maintenance treatment phase, remission can be achieved in more than 80% of cases. However, the relapse-free surv

UTTER

Microscopic Polyangiitiseart disease..Anti-neutrophil cytoplasmic antibodies, usually P-ANCA/MPO-ANCA, are detected in up to 80–90% of patients with active MPA..Untreated MPA has an unfavorable course and is associated with increased mortality and end-stage renal disease (ESRD). Factors independently related to death are t

主講人